Geode Capital Management
NYMX

Geode Capital Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,678
Closed -$9.63K 4886
2023
Q2
$9.63K Hold
50,678
﹤0.01% 4718
2023
Q1
$17.2K Hold
50,678
﹤0.01% 4720
2022
Q4
$15K Hold
50,678
﹤0.01% 4805
2022
Q3
$21K Hold
50,678
﹤0.01% 4911
2022
Q2
$22K Hold
50,678
﹤0.01% 4912
2022
Q1
$63K Hold
50,678
﹤0.01% 4766
2021
Q4
$65K Sell
50,678
-53
-0.1% -$68 ﹤0.01% 4816
2021
Q3
$104K Buy
50,731
+9,086
+22% +$18.6K ﹤0.01% 4663
2021
Q2
$65K Sell
41,645
-261,410
-86% -$408K ﹤0.01% 4626
2021
Q1
$672K Buy
303,055
+3,262
+1% +$7.23K ﹤0.01% 3707
2020
Q4
$743K Buy
299,793
+2,557
+0.9% +$6.34K ﹤0.01% 3460
2020
Q3
$731K Buy
297,236
+12,406
+4% +$30.5K ﹤0.01% 3311
2020
Q2
$1.01M Buy
284,830
+243,238
+585% +$863K ﹤0.01% 3132
2020
Q1
$97K Buy
41,592
+15,420
+59% +$36K ﹤0.01% 3777
2019
Q4
$57K Hold
26,172
﹤0.01% 4072
2019
Q3
$48K Sell
26,172
-833
-3% -$1.53K ﹤0.01% 4068
2019
Q2
$39K Sell
27,005
-122,349
-82% -$177K ﹤0.01% 4106
2019
Q1
$294K Buy
149,354
+15,333
+11% +$30.2K ﹤0.01% 3620
2018
Q4
$175K Buy
134,021
+13,103
+11% +$17.1K ﹤0.01% 3712
2018
Q3
$297K Buy
120,918
+11,132
+10% +$27.3K ﹤0.01% 3628
2018
Q2
$368K Buy
109,786
+19,284
+21% +$64.6K ﹤0.01% 3530
2018
Q1
$382K Buy
90,502
+1,306
+1% +$5.51K ﹤0.01% 3487
2017
Q4
$294K Buy
89,196
+8,021
+10% +$26.4K ﹤0.01% 3545
2017
Q3
$310K Buy
81,175
+7,068
+10% +$27K ﹤0.01% 3519
2017
Q2
$326K Buy
74,107
+52,826
+248% +$232K ﹤0.01% 3511
2017
Q1
$77K Buy
21,281
+468
+2% +$1.69K ﹤0.01% 3875
2016
Q4
$55K Buy
20,813
+6,504
+45% +$17.2K ﹤0.01% 3897
2016
Q3
$46K Buy
14,309
+78
+0.5% +$251 ﹤0.01% 3923
2016
Q2
$47K Hold
14,231
﹤0.01% 3936
2016
Q1
$34 Sell
14,231
-78
-0.5% ﹤0.01% 4015
2015
Q4
$46K Buy
+14,309
New +$46K ﹤0.01% 4017